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Kidney transplantation and wait-listing rates from the in-
ternational Dialysis Outcomes and Practice Patterns Study
(DOPPS).
Background. The international Dialysis Outcomes and Prac-
tice Patterns Study (DOPPS I and II) allows description of vari-
ations in kidney transplantation and wait-listing from nationally
representative samples of 18- to 65-year-old hemodialysis pa-
tients. The present study examines the health status and socioe-
conomic characteristics of United States patients, the role of
for-profit versus not-for-profit status of dialysis facilities, and the
likelihood of transplant wait-listing and transplantation rates.
Methods. Analyses of transplantation rates were based on
5267 randomly selected DOPPS I patients in dialysis units in
the United States, Europe, and Japan who received chronic
hemodialysis therapy for at least 90 days in 2000. Left-truncated
Cox regression was used to assess time to kidney trans-
plantation. Logistic regression determined the odds of being
transplant wait-listed for a cross-section of 1323 hemodialysis
patients in the United States in 2000. Furthermore, kidney trans-
plant wait-listing was determined in 12 countries from cross-
sectional samples of DOPPS II hemodialysis patients in 2002 to
2003 (N = 4274).
Results. Transplantation rates varied widely, from very low
in Japan to 25-fold higher in the United States and 75-fold
higher in Spain (both P values <0.0001). Factors associated with
higher rates of transplantation included younger age, nonblack
race, less comorbidity, fewer years on dialysis, higher income,
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and higher education levels. The likelihood of being wait-listed
showed wide variation internationally and by United States re-
gion but not by for-profit dialysis unit status within the United
States.
Conclusion. DOPPS I and II confirmed large variations in
kidney transplantation rates by country, even after adjusting for
differences in case mix. Facility size and, in the United States,
profit status, were not associated with varying transplantation
rates. International results consistently showed higher trans-
plantation rates for younger, healthier, better-educated, and
higher income patients.
Patients who undergo kidney transplantation have
longer survival and better quality of life than patients
on either hemodialysis or peritoneal dialysis [1–5]. Fur-
thermore, the long-term cost of transplantation is lower
than remaining on either dialysis modality [6].
The number of persons treated for end-stage renal
disease (ESRD) doubled during the last decade in the
United States [7] and in Europe [8]. During that time,
the number of patients on the United States transplant
waiting list increased 2.8-fold. At the end of 2001, the Sci-
entific Registry of Transplant Recipients (SRTR) reports
that 48,405 patients were on a kidney transplant waiting
list in the United States, while only 14,343 patients re-
ceived a deceased donor kidney [9]. Similar discrepancies
between demand for and supply of organs are observed
in other countries, too [8].
Despite a 30% increase in the number of transplants
performed in the United States during the last 10 years,
a strong need continues for greater organ availability, as
indicated by the doubling from 1992 to 2001 in the annual
number of patients who died while on transplant waiting
lists. The demand for organs has outpaced supply [10].
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Previous studies from the United States have evaluated
transplantation rates by patient characteristics. These
studies have shown that blacks, women, and persons of
low socioeconomic status are less likely to receive kid-
ney transplants [2, 11]. To better understand interna-
tional trends in transplantation, the present analyses used
data from the Dialysis Outcomes and Practice Patterns
Study (DOPPS I and II) to describe patient characteris-
tics and country variations in kidney transplantation rates
from representative samples of hemodialysis facilities in
France, Germany, Italy, Japan, Spain, the United King-
dom, and the United States. The present study also exam-
ines the health status and socioeconomic characteristics
of patients in United States for-profit and not-for-profit
dialysis facilities to explore access-to-care issues.
METHODS
The DOPPS is an international, prospective, observa-
tional study of hemodialysis practice patterns and their
associated outcomes. Data for the DOPPS I were col-
lected from nationally representative samples of ran-
domly selected dialysis facilities from Europe [101 facil-
ities, 2320 adult patients (ages ≥18 years) from France,
Germany, Italy, Spain, and the United Kingdom], Japan
(65 facilities, 1651 patients), and the United States (145
facilities, 4831 patients). Further details of the DOPPS
data collection protocol and study design have been de-
scribed [12]. DOPPS II, which was initiated in 2002,
includes the addition of Australia, Belgium, Canada,
New Zealand, and Sweden to the study, bringing the
number of facilities participating up to 340, from 308 in
DOPPS I.
Excluded from most analyses here were patients with
a previous transplant and patients who were older than
65 years of age, since transplantation rates are very low
above this age [4]. Laboratory measurements, demo-
graphic factors, comorbidities, and treatment factors were
collected at patient entry into the study. Data collection
began in 1996 in the United States, 1998 in Europe, and
1999 in Japan. Patients were replaced on an ongoing basis
due to death, transplantation, change in treatment modal-
ity, withdrawal from dialysis, recovery of renal function,
or transfer to another facility.
The kidney transplant wait-listing information was
available only for randomly selected United States
DOPPS patients (N = 1323), 18 to 65 years of age, who
were receiving hemodialysis therapy for ESRD on June
1, 2000, and who had been receiving maintenance dial-
ysis for 90 days or more. The present study analyzed
the hemodialysis patient population because its data are
readily available from the DOPPS and because this pa-
tient population represents approximately 90% of all pa-
tients on the kidney transplant waiting list.
Statistical methods
Unadjusted transplant rates are reported here per 100
patient years, for ages 18 to 65 and as a contrast for ages.
A Cox proportional hazards regression, left-truncated
for time since start of dialysis, was used to assess time
to kidney transplantation, with either a living or ca-
daveric kidney donor. Patient-level characteristics and
facility-level practice patterns were examined in sepa-
rate models. Models accounted for facility clustering ef-
fects and were adjusted for age, race, sex, years with
ESRD, predialysis serum albumin, creatinine, phospho-
rus, hematocrit, nursing home status, smoking status,
hospital or nonhospital-based facility, education level,
country, body mass index (BMI), 14 summary comor-
bid conditions [coronary artery disease, congestive heart
failure, other cardiac disease, hypertension, cerebrovas-
cular disease, peripheral vasculopathy disease, diabetes
mellitus, lung disease, cancer (excluding skin cancer),
gastrointestinal bleeding, neurologic disease, psychiatric
disease, recurrent cellulitis/skin disease, and human im-
munodeficiency virus (HIV)/acquired immunodeficiency
syndrome (AIDS)], and yearly household income. Equiv-
alent income categories were provided on the Euro-
pean and Japanese questionnaires, based on United
States monetary exchange rates in 1998 for Europe and
exchange rates in 1999 for Japan. Facility-level analy-
ses excluded patients with fewer than 90 days of expo-
sure to facility practice patterns. Facility practice pat-
terns that were examined included facility type (hos-
pital vs. nonhospital-based) and size, and patient time
with a social worker. All models, except those pertaining
to country rates, were stratified by country. Clustering
effects were addressed with robust standard-error esti-
mates based on the sandwich estimator [13].
Wait-listing results were restricted to patients receiv-
ing hemodialysis for at least 90 days. This allowed suffi-
cient time for health care providers to place patients on a
transplant waiting list for a deceased donor kidney. All of
the results were limited to hemodialysis patients 18 to 65
years old, since over 85% of all kidney transplants are per-
formed on people in this age group. Logistic regression—
accounting for facility-clustering effects and adjusted for
demographics, unit type, United States geographic re-
gion, years with ESRD, and 14 comorbid conditions—was
used to determine the odds of United States hemodialy-
sis patients being on a kidney transplant waiting list. All
statistical analyses were performed with SAS software,
version 8.2 (SAS Institute, Cary, NC, USA).
RESULTS
Kidney transplantation rates
Differences by demographics. Table 1 shows the dis-
tribution of hemodialysis patient baseline characteristics.
The mean age among the 18- to 65-year-old patients was
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Table 1. Relative rate (RR) of kidney transplantation by patient characteristics among patients 18 to 65 years of agea
Measure Patients% RR transplant P value
Age years
18–34 11.8 2.44 <0.0001
35–49 31.5 2.02 <0.0001
50–65 56.7 1.00 Ref
Race
White 51.7 1.00 Ref
Black 23.3 0.35 <0.0001
Asian 20.9 0.65 0.05
Other 4.12 0.57 0.001
Gender
Male (vs. female) 59.6 1.15 0.07
Years with end-stage renal disease (per 1 year) — 0.94 <0.0001
Comorbid conditions (present vs. not)
Coronary artery disease 28.7 0.79 0.03
Congestive heart failure 27.0 0.73 0.005
Hypertension 76.0 1.23 0.05
Peripheral vasculopathy 16.9 0.61 0.001
Diabetes mellitus 35.9 0.93 0.52
Cancer (excluding skin) 6.1 0.57 0.003
Psychiatric disease 23.0 0.68 0.0002
Recurrent cellulitis/skin disease 7.2 0.48 0.003
Smoker 21.4 0.79 0.03
Income in United States dollars (missing for 54%)
>$5000 15.3 0.98 0.91
$5001–$10,000 25.8 1.00 0.98
$10,001–$20,000 25.0 1.00 Ref
$20,001–$40,000 21.6 1.40 0.01
$40,001–$75,000 9.0 1.36 0.08
>$75,000 3.4 2.62 <0.0001
Education level
Less than high school 30.6 0.81 0.06
High school or some college 39.8 1.04 0.66
College graduate 29.6 1.00 Ref
In Nursing Home (vs. not) 2.8 0.21 0.03
aRelative rate adjusted for all factors, years on hemodialysis (see Fig. 1), and for country. Total number of patients from all seven Dialysis Outcomes and Practice
Patterns Study (DOPPS) I countries = 5267.
49.5 years (not shown). Men made up 60% of the sample,
52% were white, 23% black (mostly in the United States),
and 21% Asian (19% living in Japan, 2% in the United
States). Of the patients in the sample, 36% had diabetes
mellitus and 76% had hypertension. In the sample, 21%
of the patients were smokers, and 3% lived in a nursing
home.
Table 1 also provides relative rates of transplantation.
Transplantation was inversely associated with age, with
patients 18 to 34 years old having a 2.4-fold higher rate
of transplantation than patients 50 to 65 years old. Black
and Asian patients received kidney transplants at sub-
stantially lower rates than white patients. Kidney trans-
plantation rates tended to be higher for men (RR = 1.15,
P = 0.07) than women, although this result was not signifi-
cant. Patients with a comorbid condition [coronary artery
disease, congestive heart failure, peripheral vasculopa-
thy, cancer (excluding skin), psychiatric disease, or recur-
rent cellulitis/skin disease] had significantly lower rates of
transplantation than patients without one of the comor-
bid conditions. Patients with diabetes mellitus also had a
lower rate of transplantation, although the result was not
significant. Patients with hypertension had a significantly
higher rate of transplantation (RR = 1.23, P = 0.05)
than those without hypertension. However, this associa-
tion with hypertension is largely explained by the adjust-
ment for cardiovascular disease, diabetes mellitus, and/or
peripheral vasculopathy, since removing the adjustment
substantially reduces the RR. The relative rate of kid-
ney transplantation was significantly higher for groups
with higher income and education levels. For instance,
patients whose incomes exceeded $75,000 (USD) had a
2.6-fold higher rate (P < 0.0001) of receiving a transplant
than patients with incomes between $10,001 and $20,000
(USD). Patients with less than a high school–level educa-
tion had less of a chance of transplantation (RR = 0.81, P
= 0.06) than those with a college degree or higher. There
was no significant difference in the chance of transplan-
tation for those with a high school degree or some college
versus those with a college degree or higher. Smokers had
a 21% lower chance of transplantation (RR = 0.79, P =
0.03) than nonsmokers. Nursing home patients displayed
a nearly fivefold lower rate of kidney transplantation (RR
= 0.21, P = 0.03) than those who did not live in nursing
homes. Patients with fewer than 3 years of ESRD therapy
had approximately a twofold higher rate of transplanta-
tion than did patients with 6 or more years of dialysis
(Fig. 1).
Satayathum et al: International transplantation and wait-listing rates 333
9.0
8.0
7.0
6.0
5.0
4.0
3.0
2.0
1.0
0.0U
na
dju
ste
d t
ran
sp
la
nt
 ra
te
,
pe
r 1
00
 p
at
ie
nt
 y
e
a
rs
0-0.9 1-2.9 3-5 6-8 9-11 12-14 15-17 18-20 21-23 >23
Years on hemodialysis
8.5
6.9
5.4
3.5 3.6
4.0
2.8
3.5
2.5 2.7
Fig. 1. Unadjusted transplantation rate by
years on hemodialysis for ages 18 to 65 years.
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Fig. 2. Crude kidney transplant rates for
hemodialysis patients in the Dialysis Out-
comes and Practice Patterns Study (DOPPS
I), 1997 to 2001, by age group. Abbreviations
are: SP, Spain; UK, United Kingdom; FR,
France; GE, Germany; IT, Italy; US, United
States; JA, Japan.
Table 2. Adjusted relative rate of kidney transplantation by country
Country RR Transplant P value 95% CI
France 1.52 0.004 (1.15, 2.01)
Germany 0.79 0.23 (0.54, 1.16)
Italy 0.84 0.39 (0.57, 1.24)
Japan 0.04 <0.0001 (0.02, 0.09)
Spain 3.04 <0.0001 (2.22, 4.16)
United Kingdom 1.45 0.04 (1.02, 2.05)
United States 1.00 Ref Ref
Restricted to patients aged 18 to 65 years (N = 5267). Relative rates for
transplantation were estimated by Cox proportional hazards regression, left-
truncated for time since start of dialysis and adjusted for age, race, sex, years with
end-stage renal disease (ESRD), predialysis serum albumin, serum creatinine,
serum phosphorus, hematocrit, nursing home status, yearly household income,
smoking status, hospital or nonhospital-based facility, education level, country,
body mass index (BMI), and 14 summary comorbidities. Analyses accounted
for facility clustering effects.
Differences by country. Figure 2 illustrates the crude
kidney transplantation rates by two age groups and by
country. Overall, those who were over 65 years old
had substantially fewer transplants than those 65 and
younger. Table 2 provides the adjusted relative rate
of kidney transplantation by country for those who
were 18 to 65 years old. France, Spain, and the United
Kingdom had higher rates of transplantation than the
United States, whereas Japan was found to have the low-
est rate of transplantation among the seven countries
studied.
Differences by facility characteristics. Transplantation
rates varied widely by dialysis facility. Excluding ages
above 65 years, the majority of dialysis facilities (51.8%)
had crude transplantation rates of fewer than 5 per 100
patient-years, 25.4% had rates of 5 to 10 per 100 patient-
years, and 23.8% had transplantation rates of 10 to over
40 per 100 patient-years. No pattern of association with
transplantation rates could be observed by facility size.
Furthermore, the facility practice of more frequent rou-
tine assessments by social workers was not associated
with significantly increased rates of transplantation. A
pattern of large United States geographic regional vari-
ation in kidney transplantation was seen after the analy-
ses were adjusted for regional differences in patient age,
sex, race, 14 summary comorbid conditions, incident (i.e.,
new to dialysis) patients, facility clustering, and unit type
(Fig. 3). These adjusted analyses indicated 2.4-fold higher
odds of hemodialysis patients receiving a transplant in
the Mountain region than patients in the Western South
Central region (P ≤ 0.01).
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Fig. 3. Effects of United States geographic
region on relative rate (RR) of kidney trans-
plantation. Analysis included only United
States Dialysis Outcomes and Practice Pat-
terns Study (US-DOPPS) point-prevalent
sample (June 1, 2000) and only patients who
were <65 old (N = 1323). RR is relative rate
of transplantation from Cox model, adjusted
for patient age, sex, race, 14 summary comor-
bid conditions, incident (i.e., new to dialysis)
patients, facility clustering, and unit type. See
Appendix for which states fall under each ge-
ographic region shown.
Table 3. Percentage of hemodialysis patients on kidney transplant
waiting lists (2002 and 2003)
DOPPS Sample number Kidney transplant
Country (N) waiting list%
Japan 884 10
United States 1129 24
Sweden 258 28
France 182 34
Belgium 201 35
Australia/New Zealand 274 36
Canada 290 39
Italy 253 39
Germany 300 40
Spain 254 48
United Kingdom 249 55
Dialysis Outcomes and Practice Patterns Study II prevalent cross-section,
hemodialysis patients ages 18 to 65 years.
Kidney transplant wait-listing
Differences by country and United States geographic re-
gion. The DOPPS studied 12 countries in 2002 and 2003,
with nationally representative hemodialysis facilities and
populations by country. Table 3 shows the percentage of
patients aged 18 to 65 years on kidney transplant waiting
lists. There was large variation in the percentages of pa-
tients on waiting lists, ranging from 10% in Japan to 55%
in the United Kingdom.
The United States data indicated that, for hemodial-
ysis patients aged 18 to 65 years, the percentage of pa-
tients placed on kidney transplant waiting lists varied
more than 2.5-fold across nine geographic regions, rang-
ing from 13% in the Eastern South Central region to 33%
in New England (Fig. 4).
Differences by age and race in the United States. The
DOPPS examined the likelihood of hemodialysis patients
being placed on a kidney transplant waiting list, based on
their age (18 to 65 years old) and race. Kidney transplant
wait-listing was found to decline significantly with age
(adjusted OR = 0.66 for every 10 years older, P < 0.001).
Furthermore, wait-listing was significantly lower for black
hemodialysis patients (adjusted OR = 0.59, P = 0.007)
than white. A significantly lower odds (P < 0.05) of wait-
listing was also seen for patients with congestive heart
failure, lung disease, or cancer (other than skin cancer).
These analyses were adjusted for gender, United States
region, 14 comorbid conditions, unit type, and years with
ESRD.
Hospital units and for-profit versus not-for-profit dial-
ysis units in the united States. National data from the
Centers for Medicare and Medicaid Services (CMS) in-
dicated that, for year 2000, 80% of United States dialysis
units were freestanding and 20% were hospital-based.
Furthermore, 85% of the freestanding units were cate-
gorized as for-profit units and 15% as not-for-profit. The
DOPPS used data from the CMS Provider files along with
data collected from each participating DOPPS dialysis
unit to evaluate the variation in kidney transplant wait-
listing according to dialysis unit type. As shown in Table
4, the percentage of patients on a kidney transplant wait-
ing list was 16% in not-for-profit units, 23% in for-profit
units, and 26% in all other units, including hospital-based
units. After detailed adjustment for differences in facility
clustering, United States region, age, sex, race, incident
(i.e., new to dialysis) patients, and 14 summary comorbid
conditions, the likelihood of patients being placed on a
kidney transplant waiting list did not significantly differ
among those treated in the three types of dialysis units.
DISCUSSION
The observed lower likelihood of black hemodialysis
patients than white hemodialysis patients being placed
on a kidney transplant waiting list is corroborated by
data from the SRTR. In year 2000, for approximately
116,000 ESRD patients aged 18 to 65 years, the SRTR
showed that the fraction of black patients placed on a kid-
ney transplant waiting list was 31% lower than for white
hemodialysis patients. The DOPPS analyses expanded
on this observation by adjusting for a large number of
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Fig. 4. Adjusted odds ratio (AOR) of being
on a kidney transplant waiting list, by United
States census region, ages 18 to 65 years. Point-
prevalent sample (June 1, 2000) (N = 1,323).
Adjusted OR compared to United States na-
tional average, adjusted for facility clustering,
unit type, United States regional demograph-
ics, years on hemodialysis, and 14 summary
comorbid conditions, compared with national
average. Numbers in bars indicate percentage
of patients on waiting list. See Appendix for
which states fall under each geographic region
shown.
Table 4. Odds of being on a kidney transplant waiting list by unit type
% Patients on kidney Adjusted ORa of being
Unit type Patient number (N) waiting-list (unadjusted) on kidney waiting list (95% CI) P value
For-profit
Freestanding 842 23 1.00 Ref
Not-for-profit
Freestanding 125 16 1.11 (0.54, 2.24) 0.78
All others 356 26 1.10 (0.64, 1.95) 0.69
Analysis included United States-Dialysis Outcomes and Practice Patterns Study (US-DOPPS) point-prevalent sample (June 1, 2000) of hemodialysis patients, aged
18 to 65 years, receiving chronic maintenance dialysis for 90 days or more.
aAdjusted odds ratio model was adjusted for differences in facility clustering, United States region, age, sex, race, incident (i.e., new to dialysis) patients, and 14
summary comorbid conditions (N = 1323).
comorbid conditions. The DOPPS results pertaining to
kidney transplantation and associated sociodemographic
factors showed that, independent of income and educa-
tion, blacks again were less likely than whites to receive
transplants. Prior studies have shown that black patients
have disproportionately lower transplantation and wait-
listing rates than whites [14–18]. Potential factors that
may account for lower transplant rates among blacks in-
clude attitudinal and interpersonal issues (e.g., less par-
ticipation in medical decision making and less trust in
physicians and the medical establishment [6, 11, 15]). Ad-
ditionally, there is the possibility that medical teams do
not communicate transplant benefits to minorities, the
poor, or uneducated as well as they do to others. Wolfe et
al [14] have shown that significantly lower rates of trans-
plantation in wait-listed blacks and Asians compared with
whites are explained in part by physiologic factors of dis-
tributions of human leukocyte antigen (HLA) B types
and blood groups. Roberts et al [19] found that HLA
types explain 7% of the 33% difference in transplanta-
tion rates between black and white patients. This level of
adjustment does not come close to explaining either the
differences Wolfe et al found or the differences found
in this paper. Blood type, rare HLA types, and early or
multiple wait-listing also do not explain the difference
between black and white patient transplantation rates
[2].
Results from the DOPPS indicate that after adjustment
for numerous patient characteristics, Spain had the high-
est relative rate of kidney transplantation while Japan had
the lowest. A comparison of transplant rates reported
by country registries indicates a similar pattern: Spain
(11.2 transplants per 100 dialysis patients [20]), United
Kingdom (9.3 transplants per 100 dialysis patients [21]),
United States (5.2 transplants per 100 dialysis patients
[22]), Germany (4.1 transplants per 100 dialysis patients
[23]), Italy (4.0 transplants per 100 dialysis patients [24]),
and Japan (0.3 transplants per 100 dialysis patients [25]).
Many factors could account for the international dif-
ferences seen among kidney transplantation rates. The
socioeconomic, religious, cultural, and political nature of
a country may play a large role in influencing the num-
ber of donors from a population and the patient view of
transplantation itself [26]. For instance, it may be that
Japan’s relatively low transplantation rate potentially re-
flects medical ethics rooted in tradition, which affects
outlooks on life, death, and the concept of brain death
[27]. Spain’s relatively high transplantation rate, on the
other hand, could owe to its national policy of presumed
consent for organ donation and its higher use of organs
from older donors with adequate histology, among other
factors [28]. Overall, the DOPPS results confirmed large
variations in terms of kidney transplantation rates by
country, even after adjusting for differences in case mix.
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Previous studies have reported that, on average,
younger, healthier patients, and those with higher socioe-
conomic status, had higher transplantation rates than oth-
ers [16–18]. The DOPPS showed similar results and pro-
vides detail by specific comorbid conditions. Although
the association of certain medical conditions—such as
heart disease, vascular disease, cellulitis, cancer, and psy-
chiatric disease—with significantly lower transplantation
rates may not be unexpected, it is of interest to observe
the magnitude of the reduction in transplantation rates.
The present results confirm prior findings indicating
that women have significantly lower rates of transplan-
tation than men. Garg et al [29] and Bloembergen et al
[30] speculate that women may less aggressively negoti-
ate the multiple steps needed for activation on the wait-
ing list and that attitudinal and interpersonal factors—
patient preferences, provider biases, and patient-provider
interactions—may play a role. Wolfe et al [14] confirmed
this gender gap toward wait-listing but explained much
of the lower transplantation rate for wait-listed female
candidates by their higher panel reactive antibody levels,
presumably due to prior pregnancies.
In the United States, Garg et al [29] suggested that for-
profit dialysis units had substantially lower wait-listing
rates than not-for-profit units, based on 1990 and 1993
samples of dialysis patients. The present results from the
DOPPS, based on a sample of year 2000 United States
hemodialysis patients, indicated that the percentage of
patients on the waiting list in for-profit facilities did not
significantly differ from those in not-for-profit units. Al-
though the sample rise was relatively small for not-for-
profit units, these results agree both in direction and in
statistical significance with the recent results of Ashby
et al [abstract; Ashby VB, et al, J Am Soc Nephrol
14:253A, 2003], who did not see a significant difference
(−0.5%) in kidney transplant wait-listing between for-
profit versus not-for-profit United States dialysis units,
based on over 3400 United States dialysis units in 2002.
The present analysis found no significant associations be-
tween facility size and transplantation rates, in agreement
with Alexander and Sehgal [31]. Nor could the present
analysis find a relationship between transplantation rates
and frequency of visits with social workers.
In the United States, regional factors were important
in the chance of receiving a transplant, as Port [9] and
Ashby et al [abstract; Ashby VB, et al, J Am Soc Nephrol
10:719A, 1999] have shown. Substantial regional varia-
tion in the United States in kidney transplant wait-listing
had also been observed in a study of patients starting
dialysis in 1991 to 1996 [abstract; Ashby et al, J Am Soc
Nephrol 10:719A, 1999]. The same study also indicated
large differences in kidney transplant wait-listing by in-
dividual states. The present DOPPS investigation indi-
cates that large regional differences in kidney transplant
wait-listing still exist in the United States. We did not ex-
amine to what extent United States regional differences
in kidney transplant wait-listing were related to regional
differences in organ donation or organ availability.
CONCLUSION
The DOPPS, using uniform data collection in nation-
ally representative dialysis units, shows that there is large
variation in transplantation rates by country and also
within regions of the United States. Furthermore, the
present international results consistently show that pa-
tients who are younger, healthier, with higher education
and income, have higher rates of transplantation. Finally,
transplantation rates did not significantly differ in the
United States between for-profit and not-for-profit dial-
ysis units.
The results from the waiting list investigation also show
large differences between countries and between regions
of the United States in placing hemodialysis patients on
kidney transplant waiting lists, even after adjusting for
differences in patient demographics and comorbidity.
These findings from the DOPPS suggest opportunities
to study factors in greater detail that allow certain coun-
tries, regions, and dialysis units to have high wait-listing
and transplantation rates. Greater access to transplan-
tation may be achieved by improvements at the dialy-
sis facility level by seeking living donors and increasing
placement on the waiting list for deceased donors.
APPENDIX
States in United States geographic regions (based on
United States census divisions)
New England (New Eng): Connecticut, Maine, Massachusetts, New
Hampshire, Rhode Island, Vermont
Middle Atlantic (Mid Atl): New Jersey, New York, Pennsylvania
East North Central (E N Central): Indiana, Illinois, Michigan, Ohio,
Wisconsin
West North Central (W N Central): Iowa, Kansas, Minnesota, Missouri,
Nebraska, North Dakota, South Dakota
South Atlantic (S Atl): Delaware, District of Columbia, Florida, Geor-
gia, Maryland, North Carolina, South Carolina, Virginia, West Virginia
East South Central (E S Central): Alabama, Kentucky, Mississippi, Ten-
nessee
West South Central (W S Central): Arkansas, Louisiana, Oklahoma,
Texas
Mountain (Moun): Arizona, Colorado, Idaho, New Mexico, Montana,
Utah, Nevada, Wyoming
Pacific (PAC): Alaska, California, Hawaii, Oregon, Washington
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